Table 1. Alterations in tumor perfusion after MHT treatment.

Time (h) after MHT
Parameter	Untreated	1 h	5 h	24 h
Arterial (sec)	5.2±1.8	3.4±1.9	2.1±1.0	3.4±1.1
Venous (sec)	15.1±2.6	9.7±2.4	5.8±2.1	10.2±2.9
AVTT (sec)	10.2±2.7	6.6±2.2	3.4±1.4 *	6.9±2.2
		AVTT  =  Arteriovenous transit time; n = 5

Concurrent reduction in arterial and venous flow after with MHT treatment which contributed to decreased half-life AVTT. Tabulated data represents average of ∼30 ROIs per treatment group (n = 5) where * denotes p<0.03.